What amount sold does Creative BioTherapeutics LLC report in Form D filings?

The latest linked filings report $330K sold across 3 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was Creative BioTherapeutics LLC's most recent SEC filing?

Creative BioTherapeutics LLC's most recent Form D filing was on 2023-08-22.

How many investors does Creative BioTherapeutics LLC have?

The most recent Form D filing lists 1 investor(s).

What type of securities does Creative BioTherapeutics LLC offer?

Creative BioTherapeutics LLC's SEC Form D filings indicate equity offerings.

Creative BioTherapeutics LLC

CIK: 0001899355·Biotechnology·GURNEE, IL·Limited Liability Company

Reported Sold

$330,000

Total Filings

Identified Offerings

Last Filed

Aug 22, 2023

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Biotechnology industry

SEC EDGAR

Offering filing timeline

Aug 22, 2023Form D — New notice

Reported sold: $150,000 · Target: $3,000,000

Rule 506(b)·1 investor

Feb 9, 2023Form D — New notice

Reported sold: $80,000 · Target: $8,000,000

Rule 506(b)·1 investor

Dec 15, 2021Form D — New notice

Reported sold: $100,000 · Target: $500,000

Section 4(3)·5 investors

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

No Revenues

Reported commissions across identified offerings

Amendment Rate

Latest reported sold across 3 identified offerings

$330,000

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Anita Kay Davidson

Related Person

Appears on 2 filings

Donald Joseph Davidson

Related Person

Appears on 1 filing

Donald Davidson

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Aug 22, 2023	New	$3,000,000	$150,000	1
Feb 9, 2023	New	$8,000,000	$80,000	1
Dec 15, 2021	New	$500,000	$100,000	5

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Exactics, Inc.

Biotechnology

Offering target: $1,500,000

Filed Jun 24, 2026